If there is a big payoff it is going to come from the Pharma side. Once the patent is issued, hopefully, that will become a positive catalyst. Figure a trial itself to be at least 24 months.
IMO a $15 million dollar valuation is low. I remember when VTGN went down to a $37 million dollar valuation and one good readout pushed it to a $550,000,000 valuation. These stocks are not for the feint of heart. Luckily you can chew their CBD gum to relieve all the stress the stock price brings.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.